A Pilot Study to Evaluate the Systemic Effect of Oral Supplementation With AM3 in Patients With Metabolic Syndrome.
Clinical trial NCT06158152 · RECRUITING
Trial details
- NCT number
- NCT06158152
- Sponsor
- Industrial Farmacéutica Cantabria, S.A.
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-20
- Primary completion
- 2025-11-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.